Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin in Overactive Bladder Urgency Symptoms
NCT00801944Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2004
- Primary completion
- Oct 2005
- Modality
- Orthosteric Ligands
- Countries
- 14
01
Overview
A Phase 3 trial of solifenacin in overactive bladder (OAB), sponsored by Astellas Pharma. Started Apr 2004; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00801944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801944.